In Situ Labeling of DNA Reveals Interindividual Variation in Nuclear DNA Breakdown in Hair and May Be Useful to Predict Success of Forensic Genotyping of Hair

    Sandra Szabo, Karin Jaeger, H. Fischer, Erwin Tschachler, Walther Parson, Leopold Eckhart
    Image of study
    TLDR In situ DNA labeling in hair can help predict forensic DNA analysis success.
    The study investigated the variability in nuclear DNA breakdown in hair and its impact on forensic genotyping success. By using Hoechst 33258 dye to label DNA in situ, researchers found that hair from different individuals showed varying levels of DNA remnants. This variability correlated with the amount of DNA that could be extracted and successfully amplified. The study concluded that the completeness of DNA degradation during hair formation is a polymorphic trait and that in situ DNA labeling could help predict the success of forensic DNA analysis in shed hair.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 297 results

      community Medications that cause extra hair growth

      in Research/Science  123 upvotes 1 year ago
      The post discusses the side effects of various drugs causing excess hair growth, questioning why only minoxidil is used in the hair loss industry. The conversation includes users sharing their experiences and concerns about potential side effects of these drugs, with some preferring baldness over potential health risks.

      community Minoxidil seems logistically impossible and impractical to use

      in Minoxidil  136 upvotes 1 year ago
      The post discusses concerns about the practicality of using Minoxidil foam for hair loss, including the frequency of application, preparation, coverage area, and drying time. Responses suggest that missing a dose isn't detrimental, it can be applied once a day, it works on all hair areas, and it doesn't need to be perfectly dry before application.

      community Anyone excited for CosmeRNA coming this month?

      in Product  171 upvotes 1 year ago
      CosmeRNA, a new hair loss treatment, is expected to release soon and may become part of the "big three" treatments alongside finasteride and minoxidil. It works differently from finasteride by targeting androgen receptors in hair follicles, potentially offering fewer side effects.

    Related Research

    1 / 1 results